Skye Bioscience, Inc.

SKYE
$0.78 (+ $0.03 + 3.86%)
Last updated: 2026-06-10 22:34 UTC
SKYE Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS83086J2006
CUSIP83086J200
Market Price0.78
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-1.3
Market Cap$26.7M
Book Value1.06
Price to Book0.787
Beta2.68
52w High5.75
52w Low0.79
Next Earnings DateN/A

Skye Bioscience, Inc. trades under ticker SKYE on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US83086J2006, CUSIP 83086J200.

About the Company
Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.
Price History